vinit6675's blog

According to Market Research Future (MRFR), the global spinal needles market is estimated to witness a sharp growth by 2023, in terms of value and volume. In its recently published study report, MRFR also asserts that the market would register a CAGR over 6.8% during the forecasted period (2017 – 2023). The increasing prevalence of different neurological diseases that are damaging brain and spinal nerves are driving the market growth.

The global spinal needles market is increasing rapidly, mainly due to the rising cases of spinal disorders and injuries. Additionally, the growing population is also supporting the market growth up to some extent. Moreover, digital healthcare is manifesting a more global approach with group practices and consolidations throughout spinal treatments markets, which, as a result, is providing impetus to the growth of the market.

Similarly, increasing numbers of patients suffering from neurodegenerative disorders like Alzheimer’s and Parkinson’s disease are fostering the growth of the spinal needles market. Besides, increasing healthcare expenditures and governmental support for the research and development contribute to the market growth. On the other hand, the development of alternative diagnostic tests and misconception about spinal needles among people impedes the growth of the market.

Global Spinal Needles Market – Segments

The report is segmented into five market dynamics to widen the scope of understanding,

By Type                                : Directional Spinal Needles, Atraumatic Needle Tips, and Pencil-point Needles, among others.

By Size                  :  24G, 25G, and 27G, among others.

By Application  : Diagnostics and Therapeutics.

By End-users      : Hospitals, Clinics, among others.

By Regions                          : Europe, North America, Asia Pacific, and the Rest-of-the-World (RoW).

Spinal Needles Market – Regional Analysis

North America leads the global spinal needles market with the largest market share. The regional market is largely driven by the rising numbers of spinal surgeries, increasing prevalence of different neurological diseases, and growing awareness among the people. Moreover, factors such as technological innovation, advancement in manufacturing processes, and contribution of nanotechnology, substantiate the market growth. Countries like the US and Canada play a vital role in the growth of this market. Besides, high per capita healthcare expenditures and rising R&D funding to develop new techniques are some of the significant factors that would support the growth of the market in the region. 

The European region accounts for the second position in the global spinal needles market. Well-developed healthcare sector and increasing healthcare expenditure with rising prevalence of diseases in the region, drive the regional market growth. Moreover, factors such as the financial support from the government for R&D activities, the increase in geriatric population and the increasing numbers of spinal surgeries for the treatment of spinal disorders in the region drive the market growth. The region is projected to grow at a substantial CAGR between 2017-2023. 

The spinal needles market in the Asia Pacific region is rapidly emerging as a promising market globally. The growing awareness about novel spine treatment is a major driving force behind the regional market growth. Besides, increasing healthcare expenditure and increasing government funding, are key factors influencing the growth of the APAC spinal needles market, positively. Also, rising cases of obesity disorders and the presence of a large patient population suffering from various spinal disorders are fostering the growth of the regional market. 

Global Spinal Needles Market – Competitive Analysis

Highly competitive, the spinal needles market appears to be fragmented due to the presence of major players having a strong presence internationally. To gain a substantially large share in the market, market players adopt some prevailing trends such as mergers & acquisitions, collaboration, and expansion. They invest in manufacturers from emerging economies for product developments and production activities. 

Generally, substantial investments are interpreted as capacity expansion plan and intensive R&D to obtain vast growth opportunities. Key manufacturers strive to develop innovative products which can deliver more than just safe & effective results, helping physicians to manage pain and increase their practice.


Major Players:

Players leading the spinal needles market include B. Braun (Germany), Boston Scientific (US), Medline Industries (US), BD (US), Sarstedt (UK), Smiths Medical (US), Exel International (US), Halyard Health (US), MYCO Medical (US), Medtronic (UK), Wallach Surgical (US), Novo Nordisk (Denmark), Argon Medical Devices, Inc (Netherland), Stryker Corporation (US), and Cook Medical (US), among others. 



The global canister market is slated to grow with a 7% CAGR during the forecast period covering 2017 to 2023. Market Research Future (MRFR) made an analysis of the market and realized that the market could register growth with substantial traction from sectors like pharmaceuticals, packaging industry, healthcare sector, automotive, and others. The demand for the product to store chemicals is also high, which can boost market prospects. In addition, the market is getting boosted by the rising demand set by contract manufacturing companies. This will further enjoy the traction set by nano-enabled packaging methods. 


The report on the global canisters market has been segmented on the basis of configuration, application, and end-user. These segments have data regarding factors and revenues that can impact various market decisions.  

By configuration, the global report on the canisters market has been segmented into 3 gm and above, 1–2 gm, 2–3 gm, 0.5–1 gm, and others.

By application, the global study on the canisters market has been segmented into storage, packaging, and others. The packaging segment includes nutraceuticals packaging, diagnostic packaging, pharmaceutical packaging, and others. The pharmaceutical packaging segment will enjoy notable traction. 

By end-user, the global discussion on the canisters market has been segmented into automotive, healthcare, pharmaceutical, retail industries, chemical, domestic, and others. The pharmaceutical industry will have a huge impact on the global market platform. 

Regional Analysis:

The global market for canisters is witnessing better growth in the Americas as the regional pharmaceutical sector is creating huge demand for the same. In addition, the demand for better packaging in diverse end user industries and impact landed by various investment plans in the US and Canada are expected to boost the regional market growth.

Competitive Landscape:

The global canister market is witnessing substantial growth due to the strategic moves made by companies like Swastika international co, Zibo Uni-Shine Industry Co., Ltd., Ashirwad chemicals, Stanley Black & Decker, Dyson Ltd., Electrolux Group, TTI Floor Care, Miele, Oreck Corporation, Clariant, Sanner GmbH, Eureka Forbes Ltd, and Haier Group, and others. These companies rely on methods like mergers, acquisitions, collaborations, and innovations to influence their portfolio. On the other hand, these companies are spending a substantial amount on research and development projects to influence changes through the launching and branding of products. 

Industry News:

In May 2020, BAE Systems won a contract worth $42.8 million to develop MK 41 Vertical Launching System (VLS) canister and ancillary hardware. As per the contract, the company will produce Mk 41 Vertical Launching System canisters, make an attempt to renew and produce Mk 13 Mod 0 canisters Mk 13 Mod 0, Mk 21 Mods 1 through 3 and Mk 29 Mod 0 canisters under the modification. The initial offer value of $954.5M contract was for the update and repair of Mk 41 VLS canisters that would serve the service branch and include various FMS customers from Japan, Denmark, and South Korea. The company targets July 2023 as its deadline and they will work in Dakota and Minnesota.

In May 2020, Rockler Woodworking and Hardware announced that they had made a combination of the broad tool compatibility of the FlexiPort couplers with dust containment of a canister and a reusable 10-micron filter. This endeavor marks an attempt to launch an upgrade of the dust bags that are normally available with many small power tools. The Dust Right FlexiPort Dust Canister is available with four interchangeable rubber couplers that helps in the handling of small handheld power tools.


Demand for healthcare IGS is rising substantially as users realises it advantages. Market Research Future (MRFR) projects that the global healthcare IGS market will grow at a staller CAGR of 16.7% during the forecast period (2017-2023).

Information technology is playing an important role in transforming the healthcare sector. Healthcare information governance solution (IGS) is one of the major outcomes of this integration. Healthcare IGS facilitate faster implementation of processes, boots metrics, and streamline controls. The growing trend of healthcare digitization has led to the generation of vast amount of data, which requires effective management. This is possible using healthcare IGS. These solutions allow medical services provider’s better leverage patient information through a systematic format.

Given that governments all over the world promote a robust healthcare management system, the Healthcare information governance solution (IGS) is likely to gather momentum in the forthcoming years. While IGS is aimed at converting information as business asset, it is also utilized to ensure compliance and reduce cost. Stricter norms along with rising cost of legal risk is prompting healthcare companies to seek for information governance solutions.

Factors such as rising penalties for noncompliance, growth of data-driven sub-markets such as pharmaceuticals and biotechnology, growing need for data management in healthcare, rapid adoption of IT solutions in healthcare are driving the global healthcare information governance solution (IGS) market. Efforts are also being made to reduce to cost of the solution in order to expand the user base and penetrate price-sensitive markets. Some of the other fundamental bottlenecks that are yet too addressed include fragmented data structures, poor compatibility with traditional organization structures and culture of secrecy.

Segmental Overview

MRFR’s report includes a comprehensive segmental analysis of the global healthcare information governance solution (IGS) market, which is conducted on the basis of deployment, application, type and end-user.

On the basis of deployment, the market has been segmented into in-premise and as web and cloud. Based on application, the market has been segmented into customer support, financials, records and others. By type, the market has been segmented into analytics, eDiscovery, content management, information security, information archiving and others. On the basis of end-user, the market has been segmented into hospitals and clinics, research and academics, pharmaceuticals and biotechnological industries, consulting companies and others.

Competitive Landscape

Some of the notable companies operating in the global healthcare information governance solution (IGS) include HP Autonomy (England), Information Governance Solutions, LLC. (U.S.), Google (U.S.), Hewlett Packard Enterprise Development LP (U.S.), NovaDigm Therapeutics (U.S.), Electronic Medicines Compendium (U.S.), Veritas Technologies (U.S.), Symantec Corporation (U.S.), Microsoft (U.S.), FTI Consulting, Inc. (U.S.) and iDiscovery Solutions, Inc. (U.S.)


Market Highlights

According to MRFR analysis, Intrauterine Contraceptive Devices (IUCDs) Market is expected to register a CAGR of 10.5% during the forecast period of 2019 to 2025 and was valued at USD 1364.0 Million in 2018.

Contraceptive devices are used to prevent unwanted pregnancy by restricting the natural ovulation cycle or making changes in the egg fertilization process. Intrauterine contraceptive devices are placed inside the uterus to avoid unintended pregnancy. These devices contain a string which guarantees the precise placement of the device inside the uterus and provide aid in removal. lifespan of these devices varies as per the brands, and it can last up to 3,5 and 10 years. Plastic and metal are used in manufacturing of intrauterine contraceptive devices (IUCDs). It is available in several shapes, such as coil, loop, triangle, and T-shaped.

Several market players currently dominate the global intrauterine contraceptive devices (IUCDs) market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.


The global intrauterine contraceptive devices (IUCDs) market has been segmented based on type and end user.

The market, based on type, has been divided into a hormonal intrauterine device and copper intrauterine device. Copper intrauterine devices are likely to hold the maximum market share in the global intrauterine contraceptive devices (IUCDs) market.

The end user segment of the market consists of hospitals, gynecology clinics, community health care centers, and others. The hospitals segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and undergoing medical procedures.

Key Players

Some of the key players in the Global Intrauterine Contraceptive Devices (IUCDs) Market are Bayer AG, The Cooper Companies, Inc., Pfizer Inc., HLL Lifecare Limited, OCON Healthcare, SMB Corporation, Egemen International, EUROGINE, S.L., Meril Life Sciences Pvt. Ltd., Mona Lisa N.V., Prosan International B.V., Pregna International Limited, and Others.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Asia-Pacific is anticipated to hold the largest market share. The intrauterine contraceptive devices (IUCDs) market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the presence of a large patient pool, developing the healthcare sector, and raising awareness about intrauterine contraceptive devices the region.

The Americas is anticipated to be the fastest-growing market owing to the rising number of unintended pregnancies, well-established healthcare sector, and increasing healthcare expenditure. The intrauterine contraceptive devices (IUCDs) market in the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada.

The European intrauterine contraceptive devices (IUCDs) market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The intrauterine contraceptive devices (IUCDs) market in the Middle East & Africa has been divided into the Middle East and Africa


Market Highlights

According to MRFR analysis, the global dyslexia treatment market growth is expected to register a CAGR of 6.5% during the forecast period of 2019 to 2025 and is expected to reach USD 26,884.5 Million by 2025.

The growth of the global dyslexia treatment market is driven by various factors such as increased spending in public health care on mental health drives the market growth. However, the low awareness about diagnosis and treatment of dyslexia, and the inefficient mental health infrastructure is projected to hamper the growth of the global dyslexia treatment market.

Key Players

Some of the key players in the global dyslexia treatment market are Jubilant Cadista (US), Pfizer Inc (US), Micro Labs (India), Gangwal Chemicals Pvt. Ltd (India), Srikem Labs (India), Novartis AG (UK), Purdue Pharma (US), RPG Life Sciences Ltd. Cian Healthcare Pvt. Ltd (India), GlaxoSmithKline (UK), Teva Pharmaceutical Industries Ltd (Israel), Eli Lilly & Company (US), and Wallace Pharmaceuticals Ltd (US).


The global dyslexia treatment market has been segmented based on type of dyslexia, treatment, route of administration, and end user.

The market, based on type of dyslexia, has been divided into phonological dyslexia and surface dyslexia. The phonological dyslexia segment is likely to be the largest and fastest-growing segment.

The global dyslexia treatment market has been segmented, on the basis of treatment, into drug class, tools, and educational techniques. The drug class segment is expected to be the largest segment owing to the increased funding to develop drugs to treat neurological disorders.

On the basis of end users of the market have been segmented into psychiatric institutions, rehabilitation centers, home care, and others. The mental institutions segment is expected to hold the largest share of the market due to the increasing number of treatment centers for dyslexia.


Anesthesia is the drugs that are different as they are effective painkillers or analgesics which can lead to sensation loss. These are available in three types including local, general, and regional. The local anesthesia is witnessing huge demand owing to the significant demand for the anesthesia applied to the specific part of the body. Additionally, rising cases of dental injury or caries are further supporting the demand. According to the World Health Organization (WHO), around 60% to 90% of children suffer from any dental issues, which augments demand for dental anesthesia.

Additionally, an increasing number of approvals or the clinical trials by the U.S. Food and Drugs Administration (FDA) is estimated to benefit market growth in the coming future. The other factors, such as raising awareness toward the oral health and continuous dental health checkups, advanced drug administration devices, and the economic growth of the mid-earning people globally, are driving growth of the global dental anesthetic market. However, stringent regulatory norms and the possibility of the side effects due to anesthetic drugs are restraining growth of the global dental anesthetic market. Nonetheless, increasing investment for exploration for newer medications, which comply with the more modern regulations implicated by WHO and FDA, are estimated to offer opportunities during the estimated timeframe.


The dental anesthesia market is segmented on the basis of types of anesthesia, product type, end-user, route of administration, and region.

Based on the type of anesthesia, the global dental anesthesia market is segmented into local anesthetics, general anesthetics, and others.

Based on the route of administration, the global dental anesthesia market is segmented into mandibular anesthesia, maxillary anesthesia, and others. Of these, the maxillary anesthesia is sub-segmented into field block, local infiltration, and nerve block. The local infiltration is further segmented into intraseptal injection, supraperiosteal injection, and periodontal ligament injection. The field block is segmented into periapical injection, whereas the nerve block is classified into middle superior alveolar, posterior superior alveolar, and anterior superior alveolar. The mandibular anesthesia is segmented into tissue, nerve block, or skin. The nerve block is classified into Akinosi, IAN, and Gow-Gates.

Based on end-user, the market is categorized into dental clinics, specialized dental hospitals, e-commerce, pharmacies, and drug stores, and others.

Regional Analysis:

On the basis of region, the dental anesthesia market is segmented intoAmerica, Europe, Asia Pacific, and the Middle East and Africa. Of these, the Americas is estimated to dominate the global dental anesthesia market owing to high healthcare expenditure. Additionally, strong presence of the key players in the region also likely to benefit market growth. Further, these key players are increasingly engaging in the merger and acquisition or agreement for newer product launches and for strengthening their presence in the region.

Europe is estimated to hold the second position and is likely to retain its position over the forecast period owing to increase in funding for research and exploration of newer drugs. Additionally, government support for these drugs in terms of government policies and reimbursement, which encouraged the market growth from the past few years. However, the Asia Pacific is anticipated to exhibit the fastest growth over the forecast period owing to rising patient awareness about the availability of solutions over dental problems and increasing cases of dental illness in the region. Additionally, increasing spending over healthcare in the region owing to improved lifestyle and awareness about the importance of oral hygiene in the region is likely to drive market growth in the coming years.




The importance placed on developing effective drugs that can treat a wide range of critical ailments is estimated to boost the global market. The market's report is efficiently analyzed as per MRFR, which provides outlooks for the global markets. By 2023, the market is estimated to note a 4.96% CAGR and touch USD 215,125.4 Million in revenues.

The increased financing potential of the players in the market is estimated to promote the growth of the active pharmaceutical ingredient market in the upcoming period. The augmented focus on APIs to advance medications to aid in the ongoing pandemic is further estimated to enhance the active pharmaceutical ingredient market companies.

Segmental Analysis

The segmental study of the active pharmaceutical ingredient market is carried out on the basis of the manufacturing process, type of synthesis, API formulation, application, molecule and region. The manufacturing process segment of the active pharmaceutical ingredient market consists of contract and captive manufacturing. The type of synthesis segment of the active pharmaceutical ingredient market consists of biotech and synthetic. The API formulation segment of the active pharmaceutical ingredient market consists of branded/innovative and generic API. The application segment of the active pharmaceutical ingredient market consists of oncology, neurological ailments, cardiovascular ailment, orthopedic, respiratory, urology and gastrointestinal.

The molecules segment of the active pharmaceutical ingredient market consists of a small and large molecules. The active pharmaceutical ingredient market region consists of the Americas, Europe, Asia Pacific, and other viable regions.

Regional Overview

The regional appraisal of the active pharmaceutical ingredient market consists of the Americas, Europe, Asia Pacific, and other viable regions. The Americas regional market for the active pharmaceutical ingredient is expected to hold the prime share of the worldwide market. The North American region spearheads the development of the Americas region due to the mounting technological advancement in diagnostics associated with the mounting occurrences of continued diseases and other neural states. The active pharmaceutical ingredient market in the region of Europe is estimated to recount for the following market portion through the forecast period. Numerous CMOs existing in manufacturing APIs and the intensifying requirement to develop generic drugs are expected to encourage the regional active pharmaceutical ingredient market. The APAC region's active pharmaceutical ingredient market is determined to be the promptest emerging region in the worldwide market due to the occurrence of rapidly emerging diseases in the region.

Competitive Analysis

The prominent contenders in the active pharmaceutical ingredient market are Hoffmann-La Roche Ltd (Switzerland), Novartis AG (UK), Pfizer Inc. (US), Abbott (US), Sanofi SA (France), Boehringer Ingelheim GmbH (UK), Bayer AG(UK), Merck & Co., Inc (US), GlaxoSmithKline Plc (UK), Eli Lilly and Company (US), and Teva Pharmaceutical Industries Ltd (Israel).

Industry Updates:

May 2021 AMPAC Fine Chemicals declared the growth plans for its factory on Normandy Drive in Petersburg. The business anticipates adding the extra 156 jobs over the next two to three years. The AMPAC plant development is part of a larger, prearranged cluster of pharmaceutical manufacturing stemming from a collaboration between several companies and groups to address chronic scarcities of some medications in the United States by fetching pharmaceutical manufacturing that has gone overseas back to domestic manufacture. The company has advanced manufacturing processes that decrease the cost of manufacture for active pharmaceutical ingredients.

May 2021 Sterling Pharma Solutions and OncoTEX, an oncology business and associate of the iQ Group Global bioscience investment initiative, the iQ Group Global, revealed that they have arrived at a clinical development arrangement for the production of OncoTex's novel platinum-resistant oncology drug contender, OxaliTEX, for use in clinical trials. Because of the agreement, Sterling will manufacture clinical trial material at its existing good manufacturing practice (CGMP) factory in Germantown, Wis., which can house extremely potent active pharmaceutical ingredients in completely contained manufacturing suites.


Market Overview

The Global Healthcare BPO Market 2020 is poised to register 12.3% CAGR to reach USD 449.623 billion till 2023. 

Market Highlights

A variety of trends are gaining momentum in the global healthcare BPO industry, such as the the percentage of geriatrics in the global population, the prevalence of target diseases, the the need for early diagnosis of incurable diseases, and the launch of innovative technologies. The lack of a predefined legislative system, on the other hand, greatly impedes the inflow of demand for BPO healthcare. Nevertheless, with an increasing demand for point-of-care research, back office operations, as well as customised medication, the healthcare BPO market share is increasingly expanding and the introduction of cost-effective laboratory tests and advanced analytical solutions is expected to open up new possibilities for this market's traders.

The pharmaceutical services bpo market is also poised to benefit from the vast increase in pharmaceutical industry funding from government, public and private bodies to develop an effective cure for the vast number of chronic diseases affecting the global population. The global healthcare outsourcing market is also driven by strict regulations on the safety of drug development procedures and efficiency of quality control and quality assurance guidelines governing the pharmaceutical and associated industries in a number of developed economies.

Regional Overview

In the report for regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa, the global healthcare BPO market has been examined from a geographical point of view.

In terms of growth opportunities as well as trends in the healthcare BPO sector, the North American market has remained at the forefront of these over the years. The area is also expected to continue to account for a considerable part of the revenue pie over the next several years, thanks to the presence of many pharmaceutical and bioscience firms and the presence of several leading players in the healthcare BPO sector. In addition, high healthcare expenditure, the concentration of leading players and the high rate of adoption of advanced technology in the field of healthcare BPO An important driver is widening government support for the development of the healthcare sector. In addition, market growth over the corresponding period will be boosted by demand for niche services and increasing cost savings.

During the forecast period, Europe is expected to account for the second-largest market share. In 2016, the region accounted for a 21.1% share in the global BPO market for healthcare. high healthcare revenues, increasing government support, and a well-developed healthcare sector are contributing to the European healthcare bpo market opportunities.

Due to the growing demand for software for smooth functioning in the healthcare sector and the increasing collaboration between the healthcare and IT sector, Asia-Pacific is estimated to be the fastest-growing region in the global market. India, Japan, China, Australia, the Republic of Korea and the rest of Asia Pacific constitute the Asia Pacific market. Factors that ignite growth pockets are rapidly advancing healthcare, high healthcare spending, developing healthcare industries & organisations and improving technology in the Asia Pacific market. A CAGR of 8.8 percent over the forecast period is projected to capture the market in China.

The healthcare BPO market in the Middle East and Africa is projected to expand due to the growing presence of healthcare BPOs in Saudi Arabia, Kuwait, and the UAE.  

Competitive Dashboard

The eminent players in the global healthcare BPO market are  IBM (US), ACCENTURE (Ireland), Cognizant (US), Sykes (US), HCL (India), QUINTILES (US), and INFOSYS (India).


Market Overview

Market Research Future (MRFR) reveals that the sleeping bruxism treatment market 2020 can gain a growth rate of 6.7% between 2017 and 2023 (appraisal period). The global market can procure a valuation of USD 638.2 million by 2023, adds MRFR. We will provide COVID-19 impact analysis with the report, coupled with all the significant developments in the market following the coronavirus disease outbreak.

Top Drivers and Barriers

Dentists and other dental professionals are at higher risk of getting infected with SARS-CoV-2, since they are in the proximity of the patient’s respiratory system while providing healthcare. Sleep apnea is a prevalent disorder around the world, and has gained a higher traction since the novel coronavirus pandemic, given the rising cases of obesity. However, since the COVID-19 outbreak, dentists and other medical practitioners have been making extensive use of telehealth to prevent physical contact with potentially affected patients. Video conferencing and phone consultations are also proving to be quite useful following the imposition of the global lockdown. The rising trend of AI, IoT, and other advanced technologies since the pandemic has also been favorable for the sleeping bruxism treatment industry.

The global market’s strong growth can be credited to the rising prevalence of sleeping bruxism among children. Changing lifestyle in conjunction with surging stress levels and mounting number of obstructive sleep apnea are also presumed to benefit the global market. Tooth wear and headaches are caused by sleeping bruxism and are emerging as key issues among patients, even posing risk to their lives. Therefore, consideration is being given effective techniques that can help prevent these complications, such as administration of antidepressants, muscle relaxants, mouth guard and more. In a nutshell, it is expected that the rising cases of sleep bruxism will bolster the need for effective therapeutic options like mouth guard, antidepressants and muscle relaxants in the coming years, translating into market growth.

Various medications are not completely effective when it comes to treatment of sleeping bruxism, which has given rise to researches to analyze different drugs and their efficiency. Muscle relaxants, Botox injections and anxiety and stress medications are currently the top treatment options favored by dentists for treatment. Occlusal splint, which is a sleeping bruxism treatment device, is garnering high momentum in the global industry, since it facilitates muscle relaxation, provides accurate diagnostic data, regularizes periodontal fiber proprioception and protects jaws and teeth from teeth grinding. Researches and development/R&D activities paired with product range expansion are some of the key marketing strategies that are employed by reputed vendors to stay ahead of the competition.

To illustrate, in June 2020, Formlabs boosted its proprietary 3D printing resins portfolio, which has dental, engineering and healthcare applications. Some of the key dental resins in this range include Dental LT Clear, an innovative biocompatible material that helps develop occlusal guards and splints for sleeping bruxism.

Segmental Analysis

The sleeping bruxism treatment industry can be categorized as type, diagnosis, treatment type, cause, patient type, and end-user.

Primary and secondary are the primary types of sleeping bruxism in the worldwide market. The biggest share in the global market since 2017 is owned by secondary bruxism, due to the rising cases of sleep disorder, high intake of medicines and drugs that cause dental problems and the surging prevalence of stressful lifestyles across the globe.

Treatment-based categories are medication and dental approaches. Dental approaches types are mouth guard and NTI-tss device, while the medication-based segments are anti-anxiety drugs, muscle relaxants and Botox injections.

The main causes bruxism identified in the market report are obstructive sleep apnea, sleep paralysis, gastroesophageal reflux disease (GERD), malocclusion, among others. The obstructive sleep apnea category is on track to hit USD 233.20 million by 2023, and procure an advancement rate of 7.0% over the conjectured period.

Pediatric and adult are the patient types mentioned in the report. Since 2017, the pediatric segment has remained ahead in the global market, as a result of the growing hyperactivity and anger issues among children, in addition to pain from teething and earache.

Regional Study

The Middle East and Africa or MEA, the Americas, Europe and Asia Pacific or APAC are the key regions across which the sleeping bruxism treatment market is projected to grow at varying rates during the evaluation period.

In 2017, America had seized a share of 39.1% in the global market and has remained in the lead since then. Some of the growth promoters are the mounting cases of anxiety and stress and the substantial government spending on researches. Increase in healthcare insurance schemes and the amplified demand and introduction of advanced and innovative devices in the dental industry favor the regional market. The expanding geriatric populace in the United States, Mexico and Canada is also proving to be instrumental in the market expansion.

Europe is the second most profitable market, thanks to the growing prevalence of sleeping bruxism among children and the mounting dental awareness among people. The burgeoning patient pool suffering from irregular breathing, sleep disorders and snoring also adds to the market strength in the region.

The APAC market is slated to accrue the fastest growth rate in the forthcoming years, as a result of the rising use of superior healthcare technology, rapid economic surge and the exploding population in the emerging countries. Substantial funds allocated to healthcare and the expanding pediatric population serves as growth catalysts as well. The advancing dental industry in Japan, India, China and South Korea is also fostering the market demand in the region.

Reputed Companies

A few reputed companies in the market are Dental Products LLC, Ipsen Biopharmaceuticals Inc., Ivoclar Vivadent AG, S4S Dental Laboratory, Carestream Dental, Merz Pharma GmbH & Co. KGaA, Randmark, and more.


Market Scope

The global laboratory information systems market is projected to reach a valuation of USD 20,757.12 million by 2025. It is predicted to exhibit a CAGR of 7.1% during the forecast period. It is expected to face massive demand owing to its ability to improve the efficiency of hospitals. Adoption of advanced healthcare systems in light of the recent surge of digitization of health records can work in favor of the market. Investments by healthcare IT companies and the mushrooming of hospital chains by expanding into rural areas can bolster the market growth.

Technological advances in pharmaceutical and biopharmaceutical laboratories can act as a catalyst for the market. The focus on drug discovery & development and development of assays to assess the presence of diseases can induce the need for LIS. This can expedite the process to a huge degree in adherence to GMP, GCP, and GDP standards. Availability of cloud for storing and management of huge volumes of data can fuel the global LIS market.


The global laboratory information systems (LIS) market has been segmented into application, components, and delivery.

Based on application, the global market has been segmented into clinical, drug discovery, and industrial.

Based on components, the global market has been segmented into software, hardware, and services.

Based on delivery, the global market is divided into on-premise based and cloud-based.

Regional Analysis

The global laboratory information systems (LIS) market, based on region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is likely to dominate the global laboratory information systems (LIS) market owing to the increasing adoption of healthcare IT software and subsidies and incentives from the government. It is expected to reach USD 20,757.12 million by 2025 with a CAGR of 7.1% from 2019 to 2025 owing to many key players and technologically advanced healthcare infrastructure in this region. Other factors influencing regional market growth are web-based information systems, cloud computing, and modernized healthcare infrastructure.

Europe is the second-largest market for LIS owing to increasing incidence of diseases and growing awareness about novel technologies to assist in laboratory functions. Support from government agencies owing to the ability of the software to expedite normal processes can bode well for the global laboratory information systems market. Massive demand for genomics and metabolomics can propel the market growth.

Asia-Pacific is predicted to be the fastest-growing market during the forecast period. This can be attributed to the presence of growing economies of India and China. Efforts to modernize healthcare infrastructure and presence of contract research organizations for undertaking drug development projects can work in favor of the market.

The Middle East & Africa has the least market share, due to the presence of middle-income countries, lack of healthcare awareness, and lack of advanced technology. The UAE and Saudi Arabia are major contributors to the region.

Competition Outlook

Medical Information Technology Inc., McKesson Corporation, LabWare Inc, IBM, Abbott Laboratories, Roper Industries, Thermo Fisher Scientific Inc., TCG Lifesciences Pvt. Ltd, and Cerner Corporation are key players of the global laboratory information systems market. Partnerships and distribution agreements are key strategies undertaken by players to sustain their market hold.


Pages: 1 2 »